> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Public Meeting on User Fees for OTC Monograph Drugs
- URL: https://www.fdaweb.com/public-meeting-on-user-fees-for-otc-monograph-drugs/
- Published: 2016-05-11T12:00:00.000Z
- Updated: 2026-09-14T21:02:01.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5135638

*Federal Register* Notice: FDA will hold a public meeting 6/10 to gather stakeholder input on the potential development of a user-fee program for nonprescription (over-the-counter or OTC) monograph drugs. A user-fee program would provide funding to supplement congressional non-user-fee appropriations, and would support timely and efficient FDA review of the efficacy and safety of ingredients included in or proposed for inclusion in a monograph. The agency invites public comment on a potential OTC monograph user-fee program and also invites suggestions regarding the features such a user-fee program should include. The meeting will be held from 9 a.m. to 5 p.m. EDT at FDA’s White Oak Campus, Bldg. 31 Conference Center, 10903 New Hampshire Ave., the Great Room (Rm. 1503A), Silver Spring, MD. Contact **Amy Bertha**, (301) 796-1647, email: OTCMonographUserFeeProgram@fda.hhs.gov. To view this notice, click [here.](https://www.gpo.gov/fdsys/pkg/FR-2016-05-11/pdf/2016-11098.pdf?ref=fdaweb.com)